Münchener Rückversicherungs-Gesellschaft in München

Global Specialty Insurance And Risk Management Will Define Future Resilience

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

07 Nov 24

Updated

15 Dec 25

Views

114

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

8.4%

7D

3.1%

Loading

1Y

8.4%

7D

3.1%

You can edit this narrative until Dec 16 5:10 PM. Then, changes will post as Updates.

Author's Valuation

€582.964.4% undervalued

AnalystConsensusTarget Fair Value

Shared on 15 Dec 25

Fair value Increased 0.42%

MUV2: Future Returns Will Depend On Navigating Divergent Outlooks And New Guidance

Analysts have nudged their price target on Münchener Rückversicherungs Gesellschaft in München slightly higher, with fair value rising by about EUR 2 to approximately EUR 583 as they factor in marginally stronger revenue growth expectations while broadly maintaining profit margin and valuation assumptions. Analyst Commentary Recent research updates reflect a modestly constructive stance on Münchener Rückversicherungs Gesellschaft in München, with incremental price target lifts offset by at least one downward revision, highlighting a balanced risk reward profile at current levels.

Shared on 28 Nov 25

Fair value Increased 1.95%

MUV2: Future Prospects Will Depend On Executing Amid Shifting Sector Expectations

Analysts have raised their price target for Münchener Rückversicherungs-Gesellschaft in München from €569.46 to €580.55, with modest increases in expected revenue growth cited as the primary reason for the update. Analyst Commentary Recent updates from equity research analysts highlight varied perspectives on Münchener Rückversicherungs-Gesellschaft in München's valuation and execution outlook.

Shared on 13 Nov 25

Fair value Increased 2.32%

MUV2: Future Performance Will Rely On Balancing Revenue Expansion And Margin Pressures

The analyst consensus price target for Münchener Rückversicherungs-Gesellschaft in München has increased modestly by approximately €13 to €569. Analysts cited improved revenue growth estimates, despite a slightly lower profit margin outlook.

Shared on 01 May 25

Fair value Increased 0.40%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Increased 0.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 2.39%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Increased 0.53%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 0.058%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Decreased 5.04%

AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.

AnalystConsensusTarget Fair Value

€582.96

4.4% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

6.90%

Insurance revenue growth rate

0.28%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

4.93%

Calculation

€4.97b

Earnings '28

x

16.66x

PE Ratio '28

=

€82.84b

Market Cap '28

€82.84b

Market Cap '28

/

123.54m

No. shares '28

=

€670.55

Share Price '28

€670.55 Share Price '28

Discounted to 2025 @ 4.93% p.a.

=

€580.44

Fair Value '25